Stallergenes Greer Foundation Honors Advances in Allergy Innovation Through 2025 Award Program Stallergenes Greer Foundation has announced the recipients of its 2025 Science Awards for Allergy, recognizing four researchers whose work is helping advance the understanding, diagnosis, and treatment of…
Agilent Technologies Introduces Advanced Multi-Attribute Method Solution to Streamline BioPharma Quality Control and Analytical Testing Agilent Technologies has announced the launch of a new multi-attribute method (MAM) workflow designed to help pharmaceutical and biopharmaceutical quality control laboratories adopt liquid chromatography…
Curi Bio Unveils Curiverse™ at MPS 2026, the First Closed-Loop Platform for Human-Relevant Drug Discovery Curi Bio has officially unveiled the Curiverse™ at the Microphysiological Systems World Summit 2026, introducing what the company describes as the industry’s first fully integrated…
IDEXX Enhances Fecal Dx™ Antigen Testing Platform with Advanced Taeniid Tapeworm Detection Capability IDEXX Laboratories has announced a significant expansion of its widely used Fecal Dx™ antigen testing platform, introducing new capabilities to detect taeniid tapeworm infections, including parasites from…
Baszucki Group Backs Oxford University Trial Exploring Ketogenic Therapy for Early Psychosis Baszucki Group has announced a £1.17 million grant to support a pioneering clinical trial at the University of Oxford aimed at evaluating whether a ketogenic diet could help…
ClearNote Health to Present New Validation Data for Avantect Pancreatic Cancer Test at ASCO 2026 ClearNote Health has announced that it will present new multi-cohort validation data for its Avantect Pancreatic Cancer Test during the ASCO Annual Meeting 2026, which…
Vyriad has introduced G-Link, a modular platform designed to enhance T-cell targeted lentiviral vector delivery for both in vivo and ex vivo therapeutic applications. Vyriad, Inc. has introduced a new modular adaptor protein technology called G-Link™, a platform designed to…
Jupiter Endovascular Reports Positive SPIRARE II Pivotal Trial Results at EuroPCR 2026 Jupiter Endovascular, Inc. announced positive topline results from its pivotal SPIRARE II clinical trial evaluating the company’s Vertex™ Pulmonary Embolectomy System in patients with acute intermediate-risk pulmonary embolism…
SERI Lugano Introduces Global Scientific Outreach Program Focused on Light-Based Neuroscience and Pineal Gland Research Switzerland Eye Research Institute, also known as SERI Lugano, has announced the launch of a new international scientific outreach initiative designed to expand public engagement…
Portal Innovations and New Brunswick Development Corporation Partner with Johnson & Johnson to Launch the Johnson & Johnson Exchange at the New Jersey Innovation Hub in HELIX, Strengthening New Jersey’s Position as a Leading Life Sciences and Innovation Center Portal…
AeroRx Therapeutics Reports Positive Phase 2a Results for Inhaled AERO-007 in COPD as First Nebulized LABA/LAMA Combination Candidate AeroRx Therapeutics has reported positive Phase 2a clinical data for AERO-007, an investigational nebulized fixed-dose combination therapy being developed for the treatment…
iECURE Reports Durable Response With ECUR-506 in OTC-HOPE Trial and Reduced Hyperammonemic Events in Initial Cohort iECURE has reported encouraging preliminary clinical data from the low-dose cohort of its ongoing OTC-HOPE trial evaluating ECUR-506, an investigational in vivo targeted gene…